Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), a leader in the development of differentiated targeted radiotherapies, today announced compelling preclinical data for ATNM-400, a first-in-class ...
How-To Geek on MSN

6 reasons interactive Python is a game-changer for me

Interactive Python modes are an easy way to learn new libraries. Scripting languages are easy to learn on their own because ...